![]() |
Virus Production & Purification Services |
||
|
|
Virus-Like Particles - VLP's |
||||
|
Among the promises of biotechnology is the
engineering of non-infectious but highly-immunogenic virus-like particles,
or VLP's.
Virus-like particles offer safer vaccine alternatives to the more conventional use of either infections (attenuated viruses) or cross-species Homologs (i.e. vaccinia). For details about services provided related to the construction and expression of recombinant virus-like particles, see: and for more details about large-scale purification of recombinant VLP's, see: |
||||
| Paragon Home Page | ||||
| Virus
Production & Purification |
||||
| Adenovirus
& Adeno-Associated Virus (AAV) Services |
||||
| Construction
of Recombinant Viruses - High Titer Stocks |
||||
| Large-Scale Production |
||||
| Large-Scale Purification |
||||
| Virus-Like Particles - VLP | ||||
| Bacteriophage Production & Purification Services |
||||
| Virus
& Bacteria Simulants |
||||
|
|
||||
|
Paragon Bioservices, Inc -
Johns Hopkins Bayview Research Campus Alpha Center - 5210 Eastern Avenue - Baltimore, Maryland 21224 800.545.6569 - 410.550.2919 - 410.550.2924 (fax) NIH BPA#: 263-00054123 - www.paragonbioservices.com - pbi@paragonbioservices.com |
|||
|
© 2003 Paragon Bioservices, Inc. |
||||